Search results
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 2 months agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 2 months agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Patients seek relief from spiraling drug prices. Will the Inflation Reduction Act deliver?
USA TODAY via Yahoo News· 2 years agoJackie Trapp has incurable blood cancer and takes a chemotherapy drug that cost more than $240,000...
Patients with incurable cervical cancer to be offered life-extending drug
The Independent UK via AOL· 1 year agoPatients with incurable cervical cancer are to be offered a new treatment which could give them more...
Merck scraps third prostate cancer study as Keytruda therapy disappoints
Reuters via Yahoo News· 1 year agoMerck & Co on Tuesday scrapped a late-stage trial of a combination therapy with its cancer drug...
Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?
Investor's Business Daily· 5 months agoMerck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the...
FOCUS-Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
Reuters via Yahoo Finance· 2 years agoU.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy Keytruda that can be injected under the skin, allowing it to protect its best-selling drug ...
Column: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's...
LA Times via Yahoo Finance· 1 year agoThe big drugmaker Merck wants to stifle Medicare's right to negotiate drug prices. (Mel Evans /...
5 FDA decisions to watch in the first quarter
BioPharma Dive via Yahoo Finance· 6 months agoBiotechnology is often described as an “innovation” industry, dependent on companies’ ability to invent and develop new medicines. By that metric, 2023...
Personalized cancer vaccine results are a 'home run': Moderna CEO
Yahoo Finance via AOL· 2 years agoPreliminary results from a personalized cancer vaccine jointly studied by Moderna (MRNA) and Merck...